766 related articles for article (PubMed ID: 10811847)
1. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
[TBL] [Abstract][Full Text] [Related]
2. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
3. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
[TBL] [Abstract][Full Text] [Related]
5. Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats.
Kato T; Sano M; Miyoshi S; Sato T; Hakuno D; Ishida H; Kinoshita-Nakazawa H; Fukuda K; Ogawa S
Circ Res; 2000 Nov; 87(10):937-45. PubMed ID: 11073891
[TBL] [Abstract][Full Text] [Related]
6. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.
Lu J; McKinsey TA; Nicol RL; Olson EN
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4070-5. PubMed ID: 10737771
[TBL] [Abstract][Full Text] [Related]
7. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type.
Wu H; Naya FJ; McKinsey TA; Mercer B; Shelton JM; Chin ER; Simard AR; Michel RN; Bassel-Duby R; Olson EN; Williams RS
EMBO J; 2000 May; 19(9):1963-73. PubMed ID: 10790363
[TBL] [Abstract][Full Text] [Related]
8. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo.
Antos CL; McKinsey TA; Frey N; Kutschke W; McAnally J; Shelton JM; Richardson JA; Hill JA; Olson EN
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):907-12. PubMed ID: 11782539
[TBL] [Abstract][Full Text] [Related]
9. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the human atrial myosin light chain 1 promoter by Ca2+-calmodulin-dependent signaling pathways.
Woischwill C; Karczewski P; Bartsch H; Luther HP; Kott M; Haase H; Morano I
FASEB J; 2005 Apr; 19(6):503-11. PubMed ID: 15791000
[TBL] [Abstract][Full Text] [Related]
11. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes.
Nakagawa Y; Kuwahara K; Harada M; Takahashi N; Yasuno S; Adachi Y; Kawakami R; Nakanishi M; Tanimoto K; Usami S; Kinoshita H; Saito Y; Nakao K
J Mol Cell Cardiol; 2006 Dec; 41(6):1010-22. PubMed ID: 17011572
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs.
Molkentin JD
Cardiovasc Res; 2004 Aug; 63(3):467-75. PubMed ID: 15276472
[TBL] [Abstract][Full Text] [Related]
13. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
[TBL] [Abstract][Full Text] [Related]
14. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1.
Musarò A; McCullagh KJ; Naya FJ; Olson EN; Rosenthal N
Nature; 1999 Aug; 400(6744):581-5. PubMed ID: 10448862
[TBL] [Abstract][Full Text] [Related]
15. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy.
Wilkins BJ; Molkentin JD
Biochem Biophys Res Commun; 2004 Oct; 322(4):1178-91. PubMed ID: 15336966
[TBL] [Abstract][Full Text] [Related]
16. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium.
Kolodziejczyk SM; Wang L; Balazsi K; DeRepentigny Y; Kothary R; Megeney LA
Curr Biol; 1999 Oct; 9(20):1203-6. PubMed ID: 10531040
[TBL] [Abstract][Full Text] [Related]
17. The transcription factor MEF2C mediates cardiomyocyte hypertrophy induced by IGF-1 signaling.
Muñoz JP; Collao A; Chiong M; Maldonado C; Adasme T; Carrasco L; Ocaranza P; Bravo R; Gonzalez L; Díaz-Araya G; Hidalgo C; Lavandero S
Biochem Biophys Res Commun; 2009 Oct; 388(1):155-60. PubMed ID: 19654000
[TBL] [Abstract][Full Text] [Related]
18. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis.
Youn HD; Chatila TA; Liu JO
EMBO J; 2000 Aug; 19(16):4323-31. PubMed ID: 10944115
[TBL] [Abstract][Full Text] [Related]
19. MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure.
van Oort RJ; van Rooij E; Bourajjaj M; Schimmel J; Jansen MA; van der Nagel R; Doevendans PA; Schneider MD; van Echteld CJ; De Windt LJ
Circulation; 2006 Jul; 114(4):298-308. PubMed ID: 16847152
[TBL] [Abstract][Full Text] [Related]
20. Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes.
Fiedler B; Wollert KC
Cardiovasc Res; 2004 Aug; 63(3):450-7. PubMed ID: 15276470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
